We are live on ! Find out more
PYXS icon

Pyxis Oncology
PYXS

48 hedge funds and large institutions have $24.6M invested in Pyxis Oncology in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 7

2% more funds holding

Funds holding: 47 → 48 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.89% less ownership

Funds ownership: 28% → 25.11% (-2.9%)

41% less capital invested

Capital invested by funds: $41.5M → $24.6M (-$16.9M)

Holders
48
Holders Change
+1
Holders Change %
+2.13%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
18
Reduced
7
Closed
16
Calls
$81K
Puts
–
Net Calls
+$81K
Net Calls Change
+$81K

Top Buyers

1
ECM
ExodusPoint Capital Management
New York
+$601K
2
Renaissance Technologies
Renaissance Technologies
New York
+$504K
3
BCM
Bridgeway Capital Management
Texas
+$368K
4
Two Sigma Investments
Two Sigma Investments
New York
+$344K
5
Bank of America
Bank of America
North Carolina
+$340K

Top Sellers

1
TCM
Tang Capital Management
California
-$2.2M
2
CAM
Cormorant Asset Management
Massachusetts
-$1.09M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.01M
4
Morgan Stanley
Morgan Stanley
New York
-$533K
5
Barclays
Barclays
United Kingdom
-$474K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
26
SG Americas Securities
New York
$52K +$65K +20,497 New
KWM
27
Kingsview Wealth Management
Oregon
$51.2K – – –
Cetera Investment Advisers
28
Cetera Investment Advisers
Illinois
$46.7K +$57.9K +18,260 New
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$44.8K +$17.1K +5,403 +45%
XT
30
XTX Topco
Cayman Islands
$39K +$48.3K +15,236 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$37.1K +$2.27K +715 +5%
CC
32
Centiva Capital
New York
$34.7K +$43K +13,546 New
PCM
33
Prelude Capital Management
New York
$26.5K +$32.8K +10,352 New
Osaic Holdings
34
Osaic Holdings
Arizona
$19.9K -$679 -214 -3%
UBS Group
35
UBS Group
Switzerland
$19.6K +$14.9K +4,695 +159%
JP Morgan Chase
36
JP Morgan Chase
New York
$11K -$2.28K -720 -14%
Wells Fargo
37
Wells Fargo
California
$6.32K +$974 +307 +14%
Simplex Trading
38
Simplex Trading
Illinois
$5K +$7.43K +2,342 New
NA
39
NewEdge Advisors
Louisiana
$4.59K +$4.89K +1,542 +617%
Morgan Stanley
40
Morgan Stanley
New York
$1.28K -$533K -168,076 -100%
AF
41
Allworth Financial
California
$512 +$634 +200 New
Fidelity Investments
42
Fidelity Investments
Massachusetts
$438 +$542 +171 New
PNC Financial Services Group
43
PNC Financial Services Group
Pennsylvania
$256 – – –
Group One Trading
44
Group One Trading
Illinois
$256 +$317 +100 New
WBC
45
West Branch Capital
Massachusetts
$64 – – –
GI
46
Gradient Investments
Minnesota
$3 +$3 +1 New
CAM
47
Cormorant Asset Management
Massachusetts
– -$1.09M -272,537 Closed
Point72 Asset Management
48
Point72 Asset Management
Connecticut
– -$1.01M -251,800 Closed
Barclays
49
Barclays
United Kingdom
– -$474K -118,223 Closed
Jane Street
50
Jane Street
New York
– -$302K -75,430 Closed
1
2
3

PYXS Hedge Fund Activity: Q2 2023 in Review

48 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q2 2023, worth a combined $24.6M — down 41% from $41.5M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PYXS positions and 16 closed out — a net gain of 1 holder — while 18 added to existing stakes and 7 trimmed.

The largest buyer was ExodusPoint Capital Management, adding an estimated $601K. The largest seller was Tang Capital Management, cutting an estimated $2.2M.

  • 48 institutional investors held Pyxis Oncology (PYXS) as of Q2 2023, up from 47 in Q1 2023.
  • Funds reported $24.6M of Pyxis Oncology stock for Q2 2023, down 41% quarter-over-quarter.
  • 17 funds opened new Pyxis Oncology positions in Q2 2023 and 16 closed out, a net change of +1 holder.
  • The largest Pyxis Oncology buyer in Q2 2023 was ExodusPoint Capital Management, an estimated $601K added.
  • The largest Pyxis Oncology seller in Q2 2023 was Tang Capital Management, an estimated $2.2M sold.

Based on aggregated 13F filings for Q2 2023.